Evidence map›Paper›PMID 41384037›Full record

ArticleAsian heart journal2025

L-GILZ is essential for cardiac function and protects against pressure overload-induced hypertrophy and dysfunction in mice.

Hai Ying Fu, Miki Imazu, Shin Ito, Osamu Tsukamoto, Masafumi Kitakaze

Abstract read
In one paragraph

Article in Asian heart journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hai Ying FuDepartment of Biochemistry, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, Japan.ORCID https://orcid.org/0000-0002-5058-8872
Miki ImazuDepartment of Clinical Research and Development, National Cerebral & Cardiovascular Center, Osaka, Japan.
Shin ItoDepartment of Clinical Research and Development, National Cerebral & Cardiovascular Center, Osaka, Japan.
Osamu TsukamotoDepartment of Biochemistry, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, Japan.
Masafumi KitakazeDepartment of Cardiovascular Medicine, Hanwa Memorial Hospital, Osaka, Japan.ORCID https://orcid.org/0000-0001-5157-4213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Glucocorticoid-induced leucine zipper (GILZ) deficiency has been shown to exacerbate angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction. However, the specific role of the long isoform of GILZ (L-GILZ) in cardiac function remains unclear. This study aimed to investigate the role of L-GILZ in maintaining cardiac function and its protective effects against pressure overload-induced hypertrophy and dysfunction. Methods: Institute of Cancer Research mice were used in this study. The human L-GILZ gene or short hairpin RNA targeting mouse L-GILZ was introduced via adeno-associated virus 9 under the control of the cardiac troponin-T promoter, ensuring cardiac-specific overexpression or knockdown. Luciferase and short hairpin RNA targeting LacZ served as respective controls. L-GILZ expression was analyzed by western blot analysis and real-time polymerase chain reaction, while extracellular signal-regulated kinase (ERK) phosphorylation was assessed via western blot analysis. RNA sequencing was performed to evaluate gene expression changes following L-GILZ knockdown. Pressure overload was induced by transverse aortic constriction (TAC), and echocardiography was used to assess cardiac function. Results: TAC-induced pressure overload reduced L-GILZ expression but not GILZ expression. Cardiac-specific overexpression of human L-GILZ was successfully achieved in mouse hearts, with no detectable expression in other organs. L-GILZ overexpression significantly attenuated TAC-induced cardiac hypertrophy, dysfunction, and ERK phosphorylation. Conversely, L-GILZ knockdown led to hypertrophy, cardiac dysfunction, and enhanced ERK phosphorylation. RNA sequencing revealed that L-GILZ knockdown reduced the expression of mitochondria-associated genes, including cytochrome c oxidase, adenosine triphosphate synthase, and mitochondrial nicotinamide adenine dinucleotide (reduced form) dehydrogenase. Conclusion: L-GILZ plays a critical role in maintaining cardiac function and homeostasis. Cardiac-specific overexpression of L-GILZ may serve as a potential therapeutic strategy for preventing and treating cardiac hypertrophy and heart failure.

Indexed as

Cardiac hypertrophyERK signalingHeart failureLong isoform of glucocorticoid-induced leucine zipperMitochondria-associated genes

Identifiers

PMID41384037
PMCPMC12695312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.